[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters to the Editor
July 2007

Neonatal Risks of Maternal Treatment With Mood Stabilizers

Arch Gen Psychiatry. 2007;64(7):866-867. doi:10.1001/archpsyc.64.7.866-b

Several of the drugs used to treat bipolar disorder are known teratogens.1 Maternal treatment with valproate sodium,2 carbamazepine,3 and lithium4 are each associated with an increased risk of major congenital abnormalities.

First Page Preview View Large
First page PDF preview
First page PDF preview